CUTANEOUS T-CELL LYMPHOMA REFRACTORY

This adverse event was reported 21 times

These drugs are most commonly taken by patients reporting CUTANEOUS T-CELL LYMPHOMA REFRACTORY:

# Drug Count
0 METHOTREXATE 12
1 METHOTREXATE SODIUM 12
2 BEXAROTENE 7
3 AZATHIOPRINE 6
4 CYCLOSPORINE 6
5 MYCOPHENOLATE MOFETIL 6
6 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 6
7 BRENTUXIMAB VEDOTIN 5
8 ACITRETIN 3
9 CYCLOPHOSPHAMIDE 1
See all common drugs associated with CUTANEOUS T-CELL LYMPHOMA REFRACTORY

CUTANEOUS T-CELL LYMPHOMA REFRACTORY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEXAROTENE 7 0.0053
1 ACITRETIN 3 0.0006
2 BRENTUXIMAB VEDOTIN 5 0.0005
3 IMIQUIMOD 1 0.0004
4 AZATHIOPRINE 6 0.0001
5 CYCLOSPORINE 6 0.0001
6 MYCOPHENOLATE MOFETIL 6 0.0000
7 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 6 0.0000
8 MELPHALAN HYDROCHLORIDE 1 0.0000
9 FLUDARABINE PHOSPHATE 1 0.0000
See all drugs enriched for association with CUTANEOUS T-CELL LYMPHOMA REFRACTORY

CUTANEOUS T-CELL LYMPHOMA REFRACTORY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD30-directed Immunoconjugate [EPC] 5 0.0005
1 Purine Antimetabolite [EPC] 6 0.0001
2 Calcineurin Inhibitor Immunosuppressant [EPC] 6 0.0000
3 Retinoid [EPC] 10 0.0000
4 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
5 Janus Kinase Inhibitor [EPC] 1 0.0000
6 Alkylating Drug [EPC] 1 0.0000
7 Vitamin D [EPC] 1 0.0000
8 Vitamin B12 [EPC] 1 0.0000
9 Vitamin C [EPC] 1 0.0000
See all drug classes enriched for association with CUTANEOUS T-CELL LYMPHOMA REFRACTORY